Overcoming the toxicity hurdles of genetically targeted T cells

Monica Casucci, Robert E. Hawkins, Gianpietro Dotti, Attilio Bondanza

Research output: Contribution to journalArticlepeer-review


The recent successes of clinical trials with T cells genetically modified with either clonal T cell receptors or chimeric antigen receptors have also highlighted their potential toxicities. The aim of this focused review was to describe the adverse events observed in these clinical trials and to link them to the complex biology of genetically targeted T cells. Finally, strategies to overcome these toxicities will be proposed and discussed, including the use of suicide genes and other innovative gene therapy strategies.

Original languageEnglish
Pages (from-to)123-130
Number of pages8
JournalCancer Immunology, Immunotherapy
Issue number1
Publication statusPublished - Jan 1 2015


  • Adoptive immunotherapy
  • Genetically modified T cells
  • NIBIT 2013
  • Suicide genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)


Dive into the research topics of 'Overcoming the toxicity hurdles of genetically targeted T cells'. Together they form a unique fingerprint.

Cite this